• Sonuç bulunamadı

High density lipoprotein cholesterol in coronary arterypatients: is it as low as expected?

N/A
N/A
Protected

Academic year: 2021

Share "High density lipoprotein cholesterol in coronary arterypatients: is it as low as expected?"

Copied!
2
0
0

Yükleniyor.... (view fulltext now)

Tam metin

(1)

92

High density lipoprotein cholesterol in coronary artery

patients: is it as low as expected?

Koroner arter hastalar›nda yüksek dansiteli lipoprotein kolesterol:

Beklendi¤i kadar düflük mü?

Dear Editor,

In the December 2005 issue of The Anadolu Kardiyoloji Der-gisi, I read with interest the article by the group of O¤uz on le-vels of high-density lipoprotein cholesterol (HDL-C) among Turks (1), a finding initially demonstrated by Mahley et al. (2) in the Turkish Heart Study in 1995 and confirmed later in the Tur-kish Adult Risk Factor Study (3). Both of these surveys were po-pulation-based, involved mostly apparently healthy Turkish adults and comprised in small part subjects with coronary heart disease (CHD). Overall mean values were reported as 38.3 mg/dl in 2119 men, and 45.5 mg/dl in 527 women (2). In the 2001/02 co-hort of the Turkish Adult Risk Factor Study (3) having a mean age 52 ±12 years, mean concentrations were found to be 38.0 mg/dl in 1137 men and 45.3 mg/dl in 1225 women. A rise by 1 to 1.5 mg/dl per decade of age was noted in both genders.

These values as a whole represented approximately 20% lo-wer levels than in German or US adults. Though Turks have se-veral environmental factors that tend to cause a decline in HDL-C, such as cigarette smoking, abdominal obesity, high triglyceri-de levels and setriglyceri-dentary lifestyle, it was proposed by the group of Mahley, and generally believed, that genetic factors were the major determinant of variations in HDL-C. For instance, interac-tion of the TaqIB polymorphism of CETP of the common B1B1 genotype with hypertriglyceridemia or obesity was shown to modulate HDL-C to lower levels among Turks (4). For the past 3 years, the Turkish Adult Risk Factor Study adopted the direct measurement method (without precipitation), which yields 2-3 mg/dl higher values. Mean HDL-C concentrations in the current cohort were 40.4 ±10 and 48.2 ±12 mg/dl in males and females, respectively.

In the past few years several studies, none population-ba-sed, were either consistent with the stated HDL-C levels or tur-ned out to provide higher concentrations so that some contro-versy was generated. One of the latter studies, the ICEBERG study was on coexisting dyslipidemia in hypertensive patients. It was reported that, in 943 predominantly female patients, mean HDL-C levels were 49.5 mg/dl. These represented roughly 7 mg/dl higher values than epidemiologic data, yet did not refer to the general population (5).

Uzunlulu et al. (1) aimed to contribute to the issue of low HDL-C levels among Turks in a study on subjects with or witho-ut coronary artery disease (CAD) documented by coronary angi-ograms who sought treatment or advice in two hospitals. In a to-tal of 420 subjects (mean age 58 years), HDL-C levels averaged

45 mg/dl in individuals with CAD, who formed the majority of the study sample. Women were reported to have a mean 47.7 mg/dl of HDL-C, thus exhibiting 2-mg/dl higher values than in the popu-lation-based studies a decade ago, a difference that may well be accounted for merely by the direct measurement method. In men, of whom only 43 were described as healthy, an existing dif-ference of 5 mg/dl in HDL-C between the studies cannot be con-vincingly ascribed to indicating a change in levels of Turkish males, especially in view of the fact that the study sample had mean triglyceride levels as low as 126 mg/dl, comprised cigaret-te smokers as low as 13%, and information was missing on alco-hol usage and waist circumference data all of which affect HDL-C concentrations substantially. Just as the average fasting glu-cose levels of 110 mg/dl found in the study would not represent the general Turkish population free of CHD, it is highly unlikely that the reported HDL-C levels do.

Nonetheless, the generated debate on the “true” levels of HDL-C among Turks should continue and may prove beneficial in a topic which concerns the estimated third biggest factor of population-attributable CHD morbidity (6).

Altan Onat

Emeritus Professor

Cerrahpafla Medical Faculty,

Istanbul University, Istanbul, Turkey

References

1. Uzunlulu M, O¤uz A, Tigen K. High-density lipoprotein cholesterol in coronary artery patients: is it as low as expected? Anadolu Kar-diyol Derg 2005; 5: 268-70.

2. Mahley RW, Palaoglu KE, Atak Z, Dawson-Pepin J, Langlois AM, Cheung V, et al. Turkish Heart Study: lipids, lipoproteins, and apo-lipoproteins. J Lipid Res 1995; 36: 839-59.

3. Onat A, Hergenç G, Uzunlar B, Ceyhan K, Uyarel H, Yaz›c› M, Do-¤an Y, ve ark. Türk toplumunda koroner risk faktörü olarak HDL-ko-lesterol: öngördürücülü¤ü, belirleyicileri ve iliflkileri. Türk Kardiyol Dern Arfl 2003; 31:9-16

4. Hodo¤lugil U, Williamson DW, Huang Y, Mahley RW. An interacti-on between the TaqIB polymorphism of CETP and smoking is asso-ciated with changes in plasma high-density lipoprotein cholesterol levels in Turks. Clin Genet 2005; 68: 118-27.

5. Ilerigelen B, Kabakci G, Koylan N, Kozan O, Buyukozturk K. Coexis-ting dyslipidemia in hypertensive patients (Abstr.). Atherosclerosis 2005; 6 (Suppl): 156.

6. Onat A. Ulusal kalp sa¤l›¤› politikas›: Kalp-damar hastal›klar›ndan korunma stratejileri. Türk Kardiyol Dern Arfl 2004; 32: 596-602.

Address for Correspondence: Prof.Dr. Altan Onat, Türk Kardiyoloji Derne¤i

Nispetiye Cad. 37/24 80630 Etiler-‹stanbul, Turkey Tel: 0212 351 62 17 E-posta: altonat@superonline.com

(2)

Author`s reply

Dear Editor,

We would like to thank the author of the Letter to the Editor for comments on our manuscript.

As we noted in the original article, our aim was not to detect the average HDL cholesterol levels of Turkish population. We completely agree with the authors that our study is not an epi-demiological, population-based study, and the results cannot be extrapolated to the entire population. However, the average high density lipoprotein (HDL) cholesterol of patients with

coro-nary artery disease is not expected to be higher than the gener-al population. Our HDL cholesterol results indicate the minimum limit of the population average. Also Mahley et al elegantly showed that HDL cholesterol levels of Turkish women in par-ticular are not as low as ten years ago.

Mehmet Uzunlulu

Merdivenkoy SSK Poliklinikleri Kars›s›,

Ressam Salih Ermez Caddesi, No: 14/6

Goztepe 34732 Istanbul, Turkey

Anadolu Kardiyol Derg

Referanslar

Benzer Belgeler

For the multivariable regression analysis in Model 1, variables (age, gender, medical history, medications, clinical status, laboratory variables) were entered into the

1 Department of Cardiology, Shanghai Ninth People’s Hospital, Shanghai Jiaotong University School of Medicine; Shanghai-People's Republic of China. 2 Department of

Visit-to-visit variability in low-density lipoprotein cholesterol is associated with adverse events in non-obstructive coronary artery disease.. Anatol J Cardiol 2019;

A notable previous finding that the low compared to mid-tertile of Lp(a) concentrations were indepen- dently associated with higher fasting triglyceride levels and likelihood

The results of this study showed that mean HDL-c in young- middle age male military professionals, traditional cardiovascu- lar risk factors were in almost normal levels

Thirdly, the main focus of our study was that, although Turkish population was regarded as a population with characteristically low HDL-C in relatively old studies (2, 3), we

We found the plasma MDA levels and coronary sinus neutrophil percentage to be significantly lower in patients received NAC as adjunct to crystalloid/blood cardioplegia compared

and 1996 to 2000 cohorts, a higher educational level (university or higher) was associated with higher plasma total cholesterol and LDL cholesterol levels than in men with